James C. Tsai, MD, MBA

James C. Tsai, MD, MBA, is president, New York Eye and Ear Infirmary of Mount Sinai; Delafield-Rodgers Professor and Chair, Department of Ophthalmology; Icahn School of Medicine at Mount Sinai, Mount Sinai Health System.

Articles by James C. Tsai, MD, MBA

Q&A: What’s in the glaucoma treatment pipeline?

ByJames C. Tsai, MD, MBA,Lynda Charters

January 23rd 2026

James Tsai, MD, MBA, sheds light on what is in the offing for glaucoma specialists

Why individualized glaucoma care remains essential amid uneven patient awareness

ByJames C. Tsai, MD, MBA,Lynda Charters

January 22nd 2026

James Tsai, MD, MBA, discusses his approaches given the wide diversity of patients in a major urban setting when awareness of glaucoma can range from highly educated patients to uninformed individuals.

(Image credit: AdobeStock/MarekPhotoDesign.com)

(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck

BySheryl Stevenson,Peter J. McDonnell,Nicole Bajic, MD,John Berdahl, MD,David A. Eichenbaum, MD, FASRS,Ehsan Sadri, MD, FACS,Oluwatosin U. Smith, MD,James C. Tsai, MD, MBA

April 24th 2025

From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption

(Part 1) From ophthalmology’s lockdown to lasting change: Five Aprils ago

ByPeter J. McDonnell, MD,Nicole Bajic, MD,John Berdahl, MD,David A. Eichenbaum, MD, FASRS,Ehsan Sadri, MD, FACS,Oluwatosin U. Smith, MD,James C. Tsai, MD, MBA,Sheryl Stevenson

April 24th 2025

Ophthalmologists reflect on the transformative impact of COVID-19, highlighting adaptations in patient care, safety protocols, and the rise of telemedicine.